Back to Treatments

Treatment

Bosutinib

1
Conditions
43
Trials
8,000
Participants
60%
Average Safety

Condition Evidence

Chronic myeloid leukemia

43 trials · 8,000 participants

88% effectiveness · 60% safety
Bosutinib | DFDA